Assignee
PARK TAE SUN
KR·9 granted patents·2 pending applications·7 citations·filing 2008–2012
Top patents by PatentIndex Score
11 records- 0177US8552069B2Method for treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredientPARK TAE SUN·Filed 2009·Granted Oct 8, 2013·3 cites·14 claims
- 0269US8614250B2Uses of adipic acidPARK TAE SUN·Filed 2012·Granted Dec 24, 2013·1 cites·10 claims
- 0368US8481592B2Uses of sesquiterpene derivativesPARK TAE-SUN·Filed 2008·Granted Jul 9, 2013·1 cites·3 claims
- 0466US8946283B2Composition for preventing or treating obesity, dyslipidemia, fatty liver or diabetes containing indole-3-carbinol derivative as active ingredientPARK TAE SUN·Filed 2011·Granted Feb 3, 2015·2 cites·7 claims
- 0548US8741964B2Uses of nonenalPARK TAE SUN·Filed 2012·Granted Jun 3, 2014·0 cites·10 claims
- 0646US10167507B2Metabolic diseases-related odorant receptor genes and use thereofPARK TAE SUN·Filed 2011·Granted Jan 1, 2019·0 cites·4 claims
- 0745US9040557B2Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndromePARK TAE SUN·Filed 2010·Granted May 26, 2015·0 cites·13 claims
- 0844US2011288125A1Novel use of piperinePARK TAE SUN·Filed 2011·Application pending·0 cites
- 0943US9884041B2Composition for the prevention or treatment of obesity, dyslipidaemia, fatty liver or insulin resistance syndrome, comprising piperonal as an active ingredientPARK TAE SUN·Filed 2010·Granted Feb 6, 2018·0 cites·10 claims
- 1037US2011281956A1Use of thymus capitatus extract, satureja hortensis extract, or carvacrol for treating metabolic diseasesPARK TAE SUN·Filed 2011·Application pending·0 cites
- 1136US8828954B2Use for scopolin and derivatives thereofPARK TAE SUN·Filed 2010·Granted Sep 9, 2014·0 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →